-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US45784P1012-
InsuletBörse Börse FrankfurtEURSymbol GOV
-
InsuletBörse Börse BerlinEURSymbol GOV
-
INSULET CORPBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GOV
-
INSULET CORPBörse Gettex System der Börse MünchenEURSymbol GOV
-
INSULET CORPBörse Börse StuttgartEURSymbol GOV
-
INSULET CORPBörse Börse DüsseldorfEURSymbol GOV
-
INSULET CORPBörse Quotrix System der Börse DüsseldorfEURSymbol GOV
-
InsuletBörse NasdaqISIN US45784P1012 WKN: A0MQX8USDSymbol PODD
-
ISIN US45784P1012 WKN: A0MQX8USDSymbol PODD
-
EURSymbol GOV
-
ISIN US45784P1012
WKN A0MQX8
Symbol PODD
Währung
USD
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
Insulet Corporation
Marktkapitalisierung
17.368.850.816 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
18.469.701.632 oder 16.268.000.000
Mitarbeiter
1.975 (+- 32%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.350 oder 2.600 Mitarbeiter
KGV
636.7
EBITDA 115.700.000
PEGRatio 2.7319
Buchwert 9.033
Insulet underperformed den DAX um -15 % vom 02.05.2014 bis 19.04.2017
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 186,85 EUR -1,39%
Portrait der Insulet Aktie
Das Unternehmen Insulet Corporation aus USA beschäftigt 1.975 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Gesundheitsdienstleistungen tätig.
Die Insulet Aktie konnte seit dem 02.05.2014 eine Rendite von 10% erwirtschaften.
Das Unternehmen Insulet Corporation ist in mehr als 37 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter Global X Longevity Thematic ETF gewichtet Insulet mit 1,00% im ETF.
Entdecke die 6 ETFs in denen Insulet Corporation am höchsten gewichtet ist Insgesamt in 37 ETFs enthalten
Dir gefallen die Informationen zu Insulet?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Insulet?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Insulet?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Insulet?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
33 News & Informationen zur Insulet Aktie
Renalytix Appoints Daniel J. Levangie to its Board of Directors
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic…
is Insulet Corporation (PODD) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence
NEW YORK, Aug. 18, 2021 /PRNewswire/ — From $7,276.9 million in 2020, the size of the global home-use insulin delivery devices market will increa…
Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence
/PRNewswire/ — From $7,276.9 million in 2020, the size of the global home-use insulin delivery devices market will increase to $19,087.6 million in 2030, at a…
1: Technological Innovations Remains the Key to Gain Edge among Insulin Delivery Devices Market Players
Fact.MR – A Market Research and Competitive Intelligence Provider: The global market for insulin delivery devices totalled US$ 14 Bn in the 2020.
The Worldwide Infusion Pump Industry is Expected to Reach $20.5 Billion by 2026 at a CAGR of 9.3% from 2021
/PRNewswire/ — The “Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)], Technology…
Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications And Growth Factors To 2030
DUBLIN, Aug. 6, 2021 /PRNewswire/ — The “Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030” report has been added to
Insulet Corporation (PODD) CEO Shacey Petrovic on Q2 2021 Results – Earnings Call Transcript
Insulet Corporation (NASDAQ:PODD) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Deborah Gordon – Investor Relations Shacey Petrovic – President and Chief…
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …
Insulet: Omnipod’s Creator At Ominous Levels Ahead Of Horizon Launch (NASDAQ:PODD)
Insulet is trading at overvalued levels, current financial health is questionable, innovation has been lacking, and competition is ramping up in the demographic Insulet pursues.
Infusion Pump Market worth $20.5 Billion by 2026 – Exclusive Report by MarketsandMarkets™
/PRNewswire/ — According to the new market research report “Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Devices (Volumetric,…
Insulin Pump Market Size to Surpass USD 11.5 Billion by 2028 at 15.5% CAGR – Report by Market Research Future (MRFR)
Insulin Pumps Market Share, Trends and Growth Analysis by Type (Traditional Insulin Pumps, Smart Insulin Pumps and Disposable Insulin Pumps), Accessories…
Insulet To Present At Upcoming Investor Conferences
Insulet Corporation PODD (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management
Smart Medical Devices Market Size Worth USD 23.50 Billion by 2027 at 23.5% CAGR – Report by Market Research Future (MRFR)
Smart Medical Devices Market Insights and Industry Analysis by Type (On-body (adhesive patch), Off-body (belt clip), Hand-held), By Technology…
Global Artificial Pancreas Device Systems Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts
/PRNewswire/ — The “Artificial Pancreas Device Systems (APDS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report…
Business Law Prof Blog
Information about the Law Professor Blogs Network.
Insulet To Announce Second Quarter 2021 Financial Results On August 5, 2021
Insulet Corporation PODD (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced
Notice of Settlement of Derivative Suit
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) — IN THE UNITED STATES DISTRICT COURTFOR THE DISTRICT OF MASSACHUSETTES RAQIM WALKER, derivatively on behalf…
Up 50% in the Past Year, is Insulet Stock a Buy? By StockNews
Up 50% in the Past Year, is Insulet Stock a Buy?
Insulet (PODD) Reports Positive Study Outcomes on Omnipod 5
Insulet's (PODD) Omnipod 5 shows improved glycemic outcomes for users of all age groups and reduced diabetes distress in users and respective caregivers amid other benefits.
Hedge Funds Are Selling Shinhan Financial Group Co., Ltd. (SHG)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
Should I Avoid NVR, Inc. (NVR)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…
Insulet : Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years
Insulet Corporation , the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced promising results from its latest pivotal trial for the Omnipod 5… | June 26, 2021
Insulet's Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across The Lifespan From Ages 2 To 70 Years
Insulet Corporation PODD (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced
Elastomeric Pumps Market Expected To Rise with a CAGR Of 5.9% By 2026, Estimates Delveinsight
/PRNewswire/ — DelveInsight's Elastomeric Pumps Market Insights, Competitive Landscape, and Market Forecast -2026 provides the current and forecast…
Senseonics vs. Insulet: Which Diabetes Stock Is a Better Buy? By StockNews
Senseonics vs. Insulet: Which Diabetes Stock Is a Better Buy?
Stocks That Hit 52-Week Highs On Friday
This morning 150 companies reached new 52-week highs.
Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm by market cap to set a new …
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …
Insulet (PODD) Presents At 39th Annual Healthcare Conference – Slideshow (NASDAQ:PODD)
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…
Ypsomed : reaches agreement in legal dispute with Insulet
01/04/2021 – 7:00amPress Releases Ypsomed Group
Burgdorf – Ypsomed has reached an agreement in its legal dispute with Insulet Corp…. | January 4, 2021
Top 5 Midcap ETFs for 2021
Learn about the top mid-cap ETFs and how they can be used to get broad exposure to an important segment of the equities market.